Abstract
Background: The exclusion of axillary lymph node clearance (ALNC) in patients with breast carcinoma when sentinel lymph node biopsy (SLNB) comes back negative has reduced arm morbidity and lymphedema significantly. The rate of axillary recurrence is substantially lower than expected in the early follow-up reports with a median false-negative rate of 6.7 per cent for SNB. Axillary recurrences may develop late therefore, long-term follow up reports are needed.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
